Validation of the Azeri version of the Pediatric Epilepsy Side Effects Questionnaire
Salayev Kamran1, Magalov Sharif2, Garaybayli Garay2
1Azerbaijan Medical University, 100, Mardanov qardaslari str., AZ1078, Baku, Azerbaijan. ksalayev@yahoo.com.
Insights
The Azeri version of the Pediatric Epilepsy Side Effects Questionnaire (PESQ) is a reliable tool for assessing antiepileptic drug side effects in children with epilepsy, improving quality of life monitoring.
Area of Science:
- Pediatric Neurology
- Clinical Psychology
- Pharmacology
Background:
- Long-term antiepileptic drug (AED) use in children with epilepsy can negatively impact quality of life and treatment adherence.
- Accurate assessment of AED side effects is crucial for managing pediatric epilepsy.
- Validated instruments are needed to evaluate the impact of AEDs on children's well-being.
Purpose of the Study:
- To validate the Azeri version of the Pediatric Epilepsy Side Effects Questionnaire (PESQ).
- To establish the reliability and validity of the PESQ for assessing AED side effects in children with epilepsy.
- To provide a culturally adapted tool for monitoring AED-related adverse events in Azeri-speaking populations.
Main Methods:
- The Azeri version of the PESQ was administered to caregivers of 120 children (aged 2-18) with epilepsy.
- The Strengths and Difficulties Questionnaire (SDQ) was used to screen for comorbid behavioral and emotional problems.
- Factor analysis, internal consistency assessment, and construct validity analysis were performed on the PESQ data.
Main Results:
- Principal component analysis confirmed a five-factor structure for the PESQ.
- The PESQ demonstrated strong internal consistency (Cronbach's alpha = 0.86) for the total side effects scale.
- Higher PESQ scores were observed in children receiving polytherapy, supporting construct validity. A strong correlation was found between PESQ and SDQ total scores.
Conclusions:
- The Azeri version of the PESQ is a reliable and valid instrument for assessing AED side effects in children with epilepsy.
- The PESQ can be utilized across the spectrum of epileptic syndromes.
- This validated tool aids in monitoring and managing AED side effects, potentially improving patient outcomes.
Purpose:
Long-lasting use of antiepileptic drugs in children with epilepsy negatively influences their quality of life and compliance. The purpose of this study was validation of the Azeri version of the Pediatric Epilepsy Side Effects Questionnaire (PESQ).
Methods:
We collected the PESQ from caregivers of children with epilepsy. In order to screen for comorbid behavioral and emotional problems, the Strengths and Difficulties Questionnaire (SDQ) was used. Demographic and medical data were collected through patient charts. We conducted factor analysis and assessed internal consistency and construct validity of the PESQ.
Results:
Caregivers of 120 patients with different epileptic syndromes completed the PESQ (age range 2-18; mean age 9.8 ± 4.0; male 56.7%; polytherapy 24%). The factor loading in the principal component analysis confirmed five-factor structure of the PESQ. The internal consistency coefficient of the total side effects scale of the PESQ was strong (0.86). Children receiving polytherapy showed higher scores on all subscales and the total score of the PESQ, supporting its construct validity. The total scores of the PESQ and the SDQ strongly correlated.
Conclusions:
The PESQ can be used as a reliable and valid measure assessing antiepileptic drug side effects across the epilepsy spectrum.
Related Concept Videos
Reliability and Validity
Framing Effects
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Data Validation
Nursing assessment guides are generally based on holistic models rather than medical...
Data Validation
Key parameters for method validation include:
Pharmacokinetics in Pediatric Patients: Drug Excretion


